WASHINGTON - The Food and Drug Administration on Friday approved a highly anticipated blood thinner from Eli Lilly, though the drug must carry the agency's sternest warning because of its bleeding risks.
WASHINGTON - People in the United States could get lower-cost drugs from Canada over the Internet under a plan that has passed the Senate.
TRENTON, N.J. - Merck & Co. and Portola Pharmaceuticals Inc. said Thursday they have signed an exclusive deal to develop and market an experimental drug to prevent strokes in people with a dangerous irregular heart rhythm.
NEW YORK (Reuters) - Stocks edged higher on Thursday as investors bought beaten-down technology and commodity shares, while a positive broker comment on Goldman Sachs boosted the financial sector.
WASHINGTON - A plan to raise taxes on the wealthy is emerging as the leading option among House Democrats looking to finance health care legislation that President Barack Obama wants.
WASHINGTON (Reuters) - Critics assailed the Obama administration on Wednesday for a deal with hospitals meant to cut costs, and a top Republican said the U.S. Senate may need more than a planned month to pass a bipartisan healthcare reform bill.
WASHINGTON (Reuters) - President Barack Obama said on Tuesday a government-run, public health insurance plan would be one of the best ways to bring down costs and "force the insurance companies to compete and keep them honest."
LIONVILLE, Pa. - Medical products maker West Pharmaceutical Services Inc. said Tuesday it bought the drug delivery device assets of Plastef Investissements SA for an undisclosed amount, in a move to complement its safety needles.
BIRMINGHAM, Ala. - HealthSouth Corp. is accusing fired chief executive Richard Scrushy of hiding money in offshore bank accounts and transferring assets out of his name to avoid paying court judgments.
Excitement over its Provenge cancer drug continues to build at Dendreon, the Seattle-based biotech that has seen shares hover near their all-time high for the past month.
ANNANDALE, Va. - President Barack Obama wanted to put a human face on his plans to overhaul health care, and a Virginia supporter did just that Wednesday. Fighting back tears, Debby Smith, 53, told Obama of her kidney cancer and her inability to obtain health insurance or hold a job.
ATLANTA - The percentage of Americans with private health insurance has hit its lowest mark in 50 years, according to two new government reports.
BIRMINGHAM, Ala. - A former HealthSouth Corp. finance chief has been ordered to spend three months in federal prison for his role in the $2.6 billion financial fraud that nearly wrecked the company.
WASHINGTON (Reuters) - A U.S. patent research group says it has uncovered evidence that could be used to declare AstraZeneca Plc's patent for its cholesterol fighter Crestor invalid.
ADELPHI, Md. - Government experts called for sweeping safety restrictions Tuesday on the most widely used painkiller, including reducing the maximum dose of Tylenol and eliminating prescription drugs such as Vicodin and Percocet.
NEW YORK - Pfizer is discontinuing a late-stage study of its cancer drug Sutent (SOO-tent) as an initial treatment for colon cancer because the drug is not proving effective enough.
SAN FRANCISCO (Reuters) - Wal-Mart Stores Inc , the world's largest retailer, said on Tuesday that it supports President Barack Obama's push to require large employers to offer health insurance to workers.
WASHINGTON - Senators on a key committee are putting the finishing touches on a government health insurance option that they hope will win broad support among Democrats and the public.
WASHINGTON - Wal-Mart has embraced President Barack Obama's call for requiring all large employers to offer health insurance to their workers.
NEW YORK - Teva Pharmaceutical Industries Ltd. and Antares Pharma Inc. said Monday the companies received Food and Drug Administration approval for use of the human growth hormone Tev-Tropin in a needle-free injection system.
NEW YORK - Shares of health insurance provider Universal American Corp. advanced Monday following an upgrade from a Goldman Sachs analyst, who said the company's stock price more than reflects the difficulties Universal American faces.
WASHINGTON - The Obama White House left open the possibility Sunday that the president would break a campaign promise and raise taxes on people earning less than $250,000 to support his health care overhaul agenda.
WASHINGTON - A panel of federal experts said Friday an anti-itching drug from eye care company Ista Pharmaceuticals is safe and effective, according to a government spokeswoman.
WASHINGTON - Congressional investigators said Wednesday two-thirds of the U.S. health insurance industry used a faulty database that overcharged patients for seeing doctors outside their insurance network, costing Americans billions of dollars in inflated medical bills.
INDIANAPOLIS - Managed care company Cigna Corp. said Wednesday Chairman and CEO H. Edward Hanway will retire at the end of 2009, ending a nearly decade-long run leading the company.
NEW YORK - Watson Pharmaceuticals Inc. said Wednesday it recieved Food and Drug Administration approval for a generic version of Duramed Pharmaceuticals' Plan B emergency contraceptive.
WASHINGTON - Even for a Democratic president, Barack Obama's challenge to health insurance companies and free market principles Tuesday were unusually pointed.
WASHINGTON (Reuters) - President Barack Obama said on Tuesday his healthcare overhaul needed a public insurance option to enforce market "discipline", but stopped short of saying he would veto legislation without one.
WASHINGTON - Hailed by President Barack Obama, a multi-billion-dollar promise by drug companies to narrow a Medicare drug coverage gap for seniors is valid only if Congress succeeds in passing a comprehensive health care bill encountering strong opposition from Republicans, an industry spokesman said Monday.
WASHINGTON - Don't have health insurance? Don't want to pay for it? Too bad.